Related Experiment Video
Updated: Jun 13, 2026
An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
[The latest developments in control of fungal infections in neutropenic patients]
1CRM-DF 16558 Clinica Oncovida. Instituto Especializado em Oncologia Clinica. Brasilia, Brazil.
Abstract:
Fever is the main expression of infections in immunocompromised patients and, therefore, an extremely important sign (1). Although none are pathognomonic, the several fever patterns described for infectious and inflammatory pathologies are, unfortunately, not yet proven applicable to immunocompromised patients, making the treatment of this specific group of patients an even greater challenge. Some of these patients, especially the elder and those under treatment with corticosteroids, may present with severe cases of infection and no fever, calling for more careful monitoring. In view of the diagnostic uncertainties, of the few clinical signs and of the potential for quick progression to severe infections, fever in neutropenic patients is considered a medical emergency (2, 3). Patients with a neutrophil count<500/mm3 are those who present a greater number of fever episodes. Before the era of empirical antibiotic therapy, febrile neutropenia was the cause of 70% of chemotherapeutic treatment related deaths (4). With new additions to the antimicrobial arsenal and the introduction of wide-range antibiotics, treatment outcomes for this condition improved significantly, allowing for the use of more toxic and often more efficient chemotherapy regimens.
Insights
Fever in immunocompromised patients, especially neutropenic individuals, is a medical emergency. Early recognition and prompt antibiotic therapy are crucial for improving outcomes in these vulnerable populations.
Area of Science:
- Infectious Diseases
- Oncology
- Hematology
Context:
- Fever is a critical indicator of infection in immunocompromised patients, posing diagnostic challenges.
- Immunocompromised individuals, particularly the elderly or those on corticosteroids, may not exhibit fever despite severe infections.
- Febrile neutropenia in cancer patients is a medical emergency due to potential rapid progression and high mortality rates.
Purpose:
- To highlight the significance of fever as a sign of infection in immunocompromised patients.
- To emphasize the diagnostic difficulties and challenges in managing febrile neutropenia.
- To underscore the importance of prompt management in improving treatment outcomes.
Summary:
- Fever is a key sign of infection in immunocompromised patients, but its presentation can be atypical, complicating diagnosis and treatment.
- Neutropenic patients (neutrophil count <500/mm3) experience frequent fever episodes, historically linked to high mortality during chemotherapy.
- The advent of empirical antibiotic therapy has significantly improved outcomes for febrile neutropenia, enabling more aggressive chemotherapy.
Impact:
- Improved understanding of fever's role in immunocompromised patients leads to earlier diagnosis and intervention.
- Enhanced management strategies for febrile neutropenia can reduce treatment-related mortality and morbidity.
- Advances in antimicrobial therapy have transformed the prognosis for cancer patients undergoing chemotherapy.
Related Concept Videos
01:27Cryptococcal Meningitis
01:15Antifungal Agents
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
01:28Fungal Phylum Microsporidia
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...